"Indefinite Dysplasia in IBD Increases Advanced Neoplasia Risk" - Alex Young
For patients with inflammatory bowel disease who were undergoing surveillance for colorectal neoplasia, indefinite dysplasia was associated with an increased risk for the development of advanced colorectal neoplasia, according to researchers at the Icahn School of Medicine at Mount Sinai. “In the modern era characterized by a vast expansion in medical options to control inflammation, and endoscopic advancements to enhance mucosal visualization, defining the natural history of indefinite dysplasia is fundamental to optimizing evidenced-based clinical algorithms for surveillance in IBD,” said Steven Itzkowitz, MD, professor of medicine, oncological sciences, and gastroenterology at the Icahn School of Medicine at Mount Sinai. He added, ““In the future, indefinite dysplasia should be considered in evidence-based risk-stratification models to guide optimal colorectal neoplasia surveillance and management among patients with IBD.”
— Steven Itzkowitz, MD, Professor, Medicine, Gastroenterology, Oncological Sciences, Director, GI Fellowship Program Icahn School of Medicine at Mount Sinai